Status:
COMPLETED
ACTIVATE in Public Housing
Lead Sponsor:
Charles Drew University of Medicine and Science
Conditions:
Pneumonia
Influenza
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This multilevel, multidisciplinary, theoretically based, culturally sensitive, community-engaged intervention sets out to mitigate uptake barriers and non-adherence to vaccination schedules as recomme...
Detailed Description
Vaccinations are critical for preventing infectious diseases such as influenza, meningitis, pneumonia, varicella zoster virus (VZV), and COVID-19. Despite increasing national distribution and promotio...
Eligibility Criteria
Inclusion
- Aim 3:
- identify as Latinx or African American
- age 18 or older
- reside in one of the six collaborating public housing area
- Speak either English or Spanish
- Report vaccine hesitancy
Exclusion
- Not a resident at one of the collaborating public housing areas
- Does not self-identify as African American or Latinx
- Age 17 and younger
- Unable to speak either English or Spanish
- Received all recommended vaccines for Influenza, Pneumonia, Meningitis, VZV, and COVID-19
- No reporting of vaccine hesitancy
Key Trial Info
Start Date :
July 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 2 2024
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06075732
Start Date
July 1 2024
End Date
December 2 2024
Last Update
February 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charles R. Drew University of Medicine & Science
Los Angeles, California, United States, 90059